Literature DB >> 20083519

Protein-losing enteropathy caused by gastrointestinal tract-involved Langerhans cell histiocytosis.

Haruko Shima1, Takao Takahashi, Hiroyuki Shimada.   

Abstract

Protein-losing enteropathy (PLE) is frequently complicated in patients with gastrointestinal tract-involved Langerhans cell histiocytosis (LCH); however, LCH per se is not generally included in the list of diseases that cause PLE. We report here a case of infantile PLE that presented with continuous diarrhea at the onset of LCH. She was initially diagnosed as having allergic gastroenteropathy and, thus, received intravenous prednisolone, which was thought to have induced immunodeficiency and consequently resulted in life-threatening cytomegalovirus-associated hemophagocytic syndrome and disseminated intravascular coagulation. Because chemotherapy for hemophagocytic syndrome was transiently effective for underlying LCH as well, the diagnosis of LCH was delayed until its recurrence. Gastrointestinal tract-involved LCH, a rare but highly fatal disease, should be considered for infants with refractory gastrointestinal symptoms, especially for those with PLE; endoscopic biopsy is strongly recommended for immediate diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083519     DOI: 10.1542/peds.2009-1742

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

Review 1.  Langerhans cell histiocytosis with anorectal involvement: a rare manifestation of adult disease.

Authors:  Joshua Waters; Alyssa Fajardo; Bryan Holcomb; Virgilio George; Bruce Robb; Matthew Ziegler
Journal:  Int J Colorectal Dis       Date:  2014-10-16       Impact factor: 2.571

2.  Severe Langerhans cell histiocytosis in an infant: haemophagocytic syndrome association.

Authors:  Marta Isabel Póvoas; Pedro Pereira Luís; Isabel Esteves; Anabela Ferrão
Journal:  BMJ Case Rep       Date:  2014-10-21

3.  Successful treatment with 2-chlorodeoxyadenosine of refractory pediatric Langerhans cell histiocytosis with initial involvement of the gastrointestinal tract.

Authors:  Azusa Mayumi; Toshihiko Imamura; Kenichi Sakamoto; Takeshi Ota; Shinya Osone; Ikuya Usami; Hajime Hosoi
Journal:  Int J Hematol       Date:  2019-07-26       Impact factor: 2.490

4.  A case of coexisting Warthin tumor and langerhans cell histiocytosis associated with necrosis, eosinophilic abscesses and a granulomatous reaction in intraparotid lymph nodes.

Authors:  Char Loo Tan; Gangaraju Changal Raju; Fredrik Petersson
Journal:  Rare Tumors       Date:  2011-04-04

Review 5.  Langerhans cell histiocytosis in children - a disease with many faces. Recent advances in pathogenesis, diagnostic examinations and treatment.

Authors:  Michalina Jezierska; Joanna Stefanowicz; Grzegorz Romanowicz; Wojciech Kosiak; Magdalena Lange
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837

6.  Patients with both Langerhans cell histiocytosis and Crohn's disease highlight a common role of interleukin-23.

Authors:  Egle Kvedaraite; Magda Lourda; HongYa Han; Bianca Tesi; Jenée Mitchell; Maja Ideström; Natalia Mouratidou; George Rassidakis; Tatiana von Bahr Greenwood; Fleur Cohen-Aubart; Martin Jädersten; Selma Olsson Åkefeldt; Mattias Svensson; George Kannourakis; Yenan T Bryceson; Julien Haroche; Jan-Inge Henter
Journal:  Acta Paediatr       Date:  2020-10-08       Impact factor: 2.299

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.